Structures of HIV-1-Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design
暂无分享,去创建一个
Jonathan R. McDaniel | Cinque S. Soto | U. Baxa | J. Mullikin | B. Haynes | J. Mascola | Nisc Comparative Sequencing Program | G. Chuang | I. Georgiev | L. Morris | Baoshan Zhang | T. Zhou | R. Bailer | N. Doria-Rose | M. Louder | L. Shapiro | P. Kwong | G. Georgiou | Kelly K. Lee | M. Guttman | A. McDermott | Yongping Yang | J. Gorman | P. Moore | B. Dekosky | Michael J. Ernandes | M. Pancera | A. Druz | M. Joyce | Xueling Wu | S. Narpala | Michael J. Chambers | J. Stuckey | M. Bonsignori | Lawrence Shapiro | T. Lemmin | Thaddeus M. Davenport | Sherman S. Leung | Marissa C. Jarosinski | Max M. Yang | Baoshan Zhang | Thomas Lemmin
[1] Lynn Morris,et al. New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency , 2015, Journal of Virology.
[2] Lynn Morris,et al. Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies , 2015, Nature Medicine.
[3] David Nemazee,et al. Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen , 2015, Science.
[4] G. Debnath,et al. D-101 HIV-1 neutralizing antibodies induced by native-like envelope trimers , 2016 .
[5] James B. Munro,et al. Crystal structure, conformational fixation, and entry-related interactions of mature ligand-free HIV-1 Env , 2015, Nature Structural &Molecular Biology.
[6] Daniel W. Kulp,et al. Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin Mice , 2015, Cell.
[7] Cinque S. Soto,et al. Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors , 2015, Cell.
[8] S. Zolla-Pazner,et al. The V1V2 Region of HIV-1 gp120 Forms a Five-Stranded Beta Barrel , 2015, Journal of Virology.
[9] Fabian Sievers,et al. Clustal Omega , 2014, Current protocols in bioinformatics.
[10] John P. Moore,et al. Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex , 2014, Proceedings of the National Academy of Sciences.
[11] Peter D. Kwong,et al. Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions , 2014, Science.
[12] Tongqing Zhou,et al. Structure and immune recognition of trimeric prefusion HIV-1 Env , 2014, Nature.
[13] John P. Moore,et al. CD4-induced activation in a soluble HIV-1 Env trimer. , 2014, Structure.
[14] Cinque S. Soto,et al. Transplanting Supersites of HIV-1 Vulnerability , 2014, PloS one.
[15] X. He,et al. Comparative analysis of human and mouse immunoglobulin variable heavy regions from IMGT/LIGM-DB with IMGT/HighV-QUEST , 2014, Theoretical Biology and Medical Modelling.
[16] Gwo-Yu Chuang,et al. Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-120 interface , 2014, Nature.
[17] Vidya Subramanian,et al. Broadly neutralizing influenza hemagglutinin stem-specific antibody CR8020 targets residues that are prone to escape due to host selection pressure. , 2014, Cell host & microbe.
[18] Chaim A. Schramm,et al. Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies , 2014, Nature.
[19] B. Korber,et al. Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection , 2014, AIDS.
[20] S. Zolla-Pazner,et al. Thermodynamic signatures of the antigen binding site of mAb 447-52D targeting the third variable region of HIV-1 gp120. , 2013, Biochemistry.
[21] John P. Moore,et al. A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies , 2013, PLoS pathogens.
[22] Young Do Kwon,et al. Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies. , 2013, Immunity.
[23] U. Baxa,et al. Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody , 2013, Science.
[24] Yan Liu,et al. Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120 , 2013, Nature Structural &Molecular Biology.
[25] Baoshan Zhang,et al. Structural basis for diverse N-glycan recognition by HIV-1–neutralizing V1–V2–directed antibody PG16 , 2013, Nature Structural &Molecular Biology.
[26] Ning Ma,et al. IgBLAST: an immunoglobulin variable domain sequence analysis tool , 2013, Nucleic Acids Res..
[27] Baoshan Zhang,et al. Mining the antibodyome for HIV-1–neutralizing antibodies with next-generation sequencing and phylogenetic pairing of heavy/light chains , 2013, Proceedings of the National Academy of Sciences.
[28] John P. Moore,et al. Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9 , 2013, Proceedings of the National Academy of Sciences.
[29] J. Mascola,et al. N332-Directed Broadly Neutralizing Antibodies Use Diverse Modes of HIV-1 Recognition: Inferences from Heavy-Light Chain Complementation of Function , 2013, PloS one.
[30] Guido Ferrari,et al. Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2. , 2013, Immunity.
[31] J. Mascola,et al. Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies. , 2012, Immunity.
[32] N. S. Laursen,et al. Highly Conserved Protective Epitopes on Influenza B Viruses , 2012, Science.
[33] David Nemazee,et al. Rational immunogen design to target specific germline B cell receptors , 2012, Retrovirology.
[34] Jordan R. Willis,et al. Frequency and genetic characterization of V(DD)J recombinants in the human peripheral blood antibody repertoire , 2012, Immunology.
[35] J. Bernhagen,et al. Macrophage migration inhibitory factor covalently complexed with phenethyl isothiocyanate. , 2012, Acta crystallographica. Section F, Structural biology and crystallization communications.
[36] M. Nussenzweig,et al. Structural basis for germline gene usage of a potent class of antibodies targeting the CD4 binding site of HIV-1 gp120 , 2012, Retrovirology.
[37] Gwo-Yu Chuang,et al. A Short Segment of the HIV-1 gp120 V1/V2 Region Is a Major Determinant of Resistance to V1/V2 Neutralizing Antibodies , 2012, Journal of Virology.
[38] James E. Crowe,et al. Human Peripheral Blood Antibodies with Long HCDR3s Are Established Primarily at Original Recombination Using a Limited Subset of Germline Genes , 2012, PloS one.
[39] Thomas B Kepler,et al. B-cell–lineage immunogen design in vaccine development with HIV-1 as a case study , 2012, Nature Biotechnology.
[40] Young Do Kwon,et al. Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9 , 2011, Nature.
[41] Pham Phung,et al. Broad neutralization coverage of HIV by multiple highly potent antibodies , 2011, Nature.
[42] Ron Diskin,et al. Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding , 2011, Science.
[43] Mario Roederer,et al. Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing , 2011, Science.
[44] T. Kepler,et al. Analysis of a Clonal Lineage of HIV-1 Envelope V2/V3 Conformational Epitope-Specific Broadly Neutralizing Antibodies and Their Inferred Unmutated Common Ancestors , 2011, Journal of Virology.
[45] Mario Roederer,et al. Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1 , 2010, Science.
[46] Tongqing Zhou,et al. Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01 , 2010, Science.
[47] J. Mascola,et al. Crystal Structure of PG16 and Chimeric Dissection with Somatically Related PG9: Structure-Function Analysis of Two Quaternary-Specific Antibodies That Effectively Neutralize HIV-1 , 2010, Journal of Virology.
[48] D. Burton,et al. Structure and function of broadly reactive antibody PG16 reveal an H3 subdomain that mediates potent neutralization of HIV-1 , 2010, Proceedings of the National Academy of Sciences.
[49] Holly Janes,et al. Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies , 2009, Journal of Virology.
[50] Tongqing Zhou,et al. Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120 , 2009, Science.
[51] Pham Phung,et al. Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target , 2009, Science.
[52] Richard T. Wyatt,et al. Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals , 2009, Nature.
[53] Tongqing Zhou,et al. Structural definition of a conserved neutralization epitope on HIV-1 gp120 , 2007, Nature.
[54] J. Mascola,et al. Efficient protein boosting after plasmid DNA or recombinant adenovirus immunization with HIV-1 vaccine constructs. , 2007, Vaccine.
[55] Laxmikant V. Kalé,et al. Scalable molecular dynamics with NAMD , 2005, J. Comput. Chem..
[56] David N Mastronarde,et al. Automated electron microscope tomography using robust prediction of specimen movements. , 2005, Journal of structural biology.
[57] B. Laubert,et al. Structural analysis of a set of proteins resulting from a bacterial genomics project , 2005, Proteins.
[58] Wayne C Koff,et al. HIV vaccine design and the neutralizing antibody problem , 2004, Nature Immunology.
[59] T. Zhou,et al. Enhancing protein crystallization through precipitant synergy. , 2003, Structure.
[60] Ping Zhu,et al. Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition , 2003, Science.
[61] Cinque S. Soto,et al. Evaluating conformational free energies: The colony energy and its application to the problem of loop prediction , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[62] Gianni Cesareni,et al. Unusual Binding Properties of the SH3 Domain of the Yeast Actin-binding Protein Abp1 , 2002, The Journal of Biological Chemistry.
[63] M. Nussenzweig,et al. Immunoglobulin heavy chain expression shapes the B cell receptor repertoire in human B cell development. , 2001, The Journal of clinical investigation.
[64] Z. Xiang,et al. Extending the accuracy limits of prediction for side-chain conformations. , 2001, Journal of molecular biology.
[65] S. L. Mayo,et al. Designed protein G core variants fold to native‐like structures: Sequence selection by ORBIT tolerates variation in backbone specification , 2001, Protein science : a publication of the Protein Society.
[66] J. Mccammon,et al. Situs: A package for docking crystal structures into low-resolution maps from electron microscopy. , 1999, Journal of structural biology.
[67] J. Sodroski,et al. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody , 1998, Nature.
[68] Young Do Kwon,et al. Crystal structure , conformational fixation , and entry-related interactions of mature ligand-free HIV-1 Env , 2016 .
[69] STRUCTURAL AND FUNCTIONAL ANALYSIS , 2015 .
[70] David C Montefiori,et al. Measuring HIV neutralization in a luciferase reporter gene assay. , 2009, Methods in molecular biology.
[71] Wen Jiang,et al. EMAN2: an extensible image processing suite for electron microscopy. , 2007, Journal of structural biology.
[72] Lei Xie,et al. Using multiple structure alignments, fast model building, and energetic analysis in fold recognition and homology modeling , 2003, Proteins.
[73] Z. Otwinowski,et al. Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.